Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Psychiatry Research
|
December 31, 2016
Revisiting stigma: Exposure to Tourette in an ordinary setting increases stigmatization
Menachem Ben-Ezra, Sharon Anavi-Goffer, Ella Arditi, et al.
Scientific Reports
|
November 23, 2019
Detection of Impending Aggressive Outbursts in Patients with Psychiatric Disorders: Violence Clues from Dogs
Uriel Bakeman, Hodaya Eilam, Clara Moray Schild, et al.
The Journal of Biological Chemistry
|
October 27, 2011
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids
Sharon Anavi-Goffer, Gemma Baillie, Andrew J Irving, et al.
Chemistry & Biology
|
August 27, 2011
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists
Wolfgang Schuehly, Juan Manuel Viveros Paredes, Jonas Kleyer, et al.
Journal of Medicinal Chemistry
|
November 14, 2003
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region
Sean D McAllister, Gulrukh Rizvi, Sharon Anavi-Goffer, et al.
International Journal of Molecular Sciences
|
July 12, 2025
A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB<sub>1</sub> and CB<sub>2</sub> Receptor Signalling
Victoria Gorberg, Tamar Harpaz, Emilya Natali Shamir, et al.
British Journal of Pharmacology
|
July 2, 2010
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
Lesley A Ford, Anke J Roelofs, Sharon Anavi-Goffer, et al.
The Journal of Biological Chemistry
|
June 28, 2007
Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms
Sharon Anavi-Goffer, Daniel Fleischer, Dow P Hurst, et al.
Molecular Pharmacology
|
November 20, 2012
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity
Gemma L Baillie, James G Horswill, Sharon Anavi-Goffer, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Psychiatry Research
|
December 31, 2016
Revisiting stigma: Exposure to Tourette in an ordinary setting increases stigmatization
Menachem Ben-Ezra, Sharon Anavi-Goffer, Ella Arditi, et al.
Scientific Reports
|
November 23, 2019
Detection of Impending Aggressive Outbursts in Patients with Psychiatric Disorders: Violence Clues from Dogs
Uriel Bakeman, Hodaya Eilam, Clara Moray Schild, et al.
The Journal of Biological Chemistry
|
October 27, 2011
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids
Sharon Anavi-Goffer, Gemma Baillie, Andrew J Irving, et al.
Chemistry & Biology
|
August 27, 2011
Mechanisms of osteoclastogenesis inhibition by a novel class of biphenyl-type cannabinoid CB(2) receptor inverse agonists
Wolfgang Schuehly, Juan Manuel Viveros Paredes, Jonas Kleyer, et al.
Journal of Medicinal Chemistry
|
November 14, 2003
An aromatic microdomain at the cannabinoid CB(1) receptor constitutes an agonist/inverse agonist binding region
Sean D McAllister, Gulrukh Rizvi, Sharon Anavi-Goffer, et al.
International Journal of Molecular Sciences
|
July 12, 2025
A Tourette Syndrome/ADHD-like Phenotype Results from Postnatal Disruption of CB<sub>1</sub> and CB<sub>2</sub> Receptor Signalling
Victoria Gorberg, Tamar Harpaz, Emilya Natali Shamir, et al.
British Journal of Pharmacology
|
July 2, 2010
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells
Lesley A Ford, Anke J Roelofs, Sharon Anavi-Goffer, et al.
The Journal of Biological Chemistry
|
June 28, 2007
Helix 8 Leu in the CB1 cannabinoid receptor contributes to selective signal transduction mechanisms
Sharon Anavi-Goffer, Daniel Fleischer, Dow P Hurst, et al.
Molecular Pharmacology
|
November 20, 2012
CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity
Gemma L Baillie, James G Horswill, Sharon Anavi-Goffer, et al.
Page
of 2